Pier 88 Investment Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1
Closed -$305 112
2025
Q1
$305 Hold
1
﹤0.01% 104
2024
Q4
$332 Hold
1
﹤0.01% 96
2024
Q3
$334 Sell
1
-1,829
-100% -$695K ﹤0.01% 91
2024
Q2
$754K Buy
1,830
+720
+65% +$285K 0.17% 70
2024
Q1
$449K Sell
1,110
-630
-36% -$222K 0.11% 68
2023
Q4
$533K Sell
1,740
-1,280
-42% -$346K 0.13% 60
2023
Q3
$731K Buy
+3,020
New +$772K 0.18% 69

Other funds holding MEDP

Pier 88 Investment Partners's MEDP Position: Q2 2025 in Review

Pier 88 Investment Partners sold out of Medpace (MEDP) in Q2 2025, closing a stake of 1 share — an estimated $305 sold.

Pier 88 Investment Partners first reported a position in MEDP in Q3 2023 and held it in 7 quarters. The position peaked at $754K in Q2 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • Pier 88 Investment Partners reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
  • Pier 88 Investment Partners sold 1 Medpace share in Q2 2025, an estimated $305.
  • Pier 88 Investment Partners first reported a position in Medpace in Q3 2023 and held it in 7 quarters.
  • Pier 88 Investment Partners's Medpace position peaked at $754K in Q2 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Pier 88 Investment Partners's 13F filing for Q2 2025, filed 7 Aug 2025.